Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
Chronic hepatitis C (CHC) is characterised by hepatic fibrosis, used as a proxy measure of prognosis. Liver biopsy is a flawed reference standard and serum markers of fibrosis offer an attractive alternative.
|Title:||Performance of serum marker panels for liver fibrosis in chronic hepatitis C.|
|Keywords:||Biological Markers, Disease Progression, Hepatitis C, Chronic, Humans, Liver Cirrhosis, Prognosis, Severity of Illness Index|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)
Archive Staff Only